Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SBSI | MCBS |
|---|---|---|
| Price | $30.10 | $34.56 |
| Change today | ▼ 0.30% | ▼ 0.86% |
| Market cap | $897.22M | $994.68M |
| Return, 3 months | -11.3% | -2.0% |
| Return, year to date | +2.5% | +33.6% |
| Return, 1 year | +11.6% | +32.9% |
| P/E (TTM) | 11.8 | 12.0 |
| P/B | 1.0 | 1.8 |
| P/E percentile vs own 5y | 63rd | 69th |
| Dividend yield | 4.78% | 3.01% |
| Revenue growth (YoY, latest qtr) | +7.6% | +31.3% |
| Net profit growth (YoY) | +23.0% | +31.5% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 30.6% | 44.3% |
| Return on equity | 9.0% | 15.9% |
| Analyst target vs. price | +19.6% | +10.0% |
| Analyst buy share | 0% | 0% |
| RSI (14) | 34 | 44 |
| 30-day volatility | 15.2% | 14.4% |
| Max drawdown, 1 year | -14.9% | -13.4% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Hold | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
